Pharmaceutical Supply – CEFAZOLIN INJECTION (NSN: 6505014802501)

The contract entails the supply and delivery of 3,000 units of sterile CEFAZOLIN INJECTION to a U.S. Navy vessel stationed overseas, ensuring strict compliance with FDA current Good Manufacturing Practices and Department of Defense logistics standards. The product is identified by the National Stock Number 6505014802501 and is being procured under a subcontract managed by the Defense Logistics Agency on behalf of the Department of Defense. All units must meet stringent quality and sterility requirements suitable for military medical use in remote and operational environments, with delivery coordinated to align with naval deployment schedules and operational readiness needs. The contract was posted on July 15, 2026, and is administered through the DIBBS system under contract number SPE2DX25D8022 with delivery order SPE2D926F7352. The NAICS code 325412 confirms the industry classification as pharmaceutical and medicine manufacturing. While the location of performance and point of contact are not specified, the end use is clearly tied to a mobile U.S. Navy platform, requiring adherence to military supply chain protocols, including proper documentation, packaging, labeling, and temperature-controlled transport. The procurement supports the health and operational capability of deployed personnel, emphasizing reliability, traceability, and regulatory compliance throughout the supply chain.